|
REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
|
12
|
1.23e-10
|
8.01e-09
|
1.11000
|
5.55e-01
|
-0.959000
|
8.73e-04
|
8.71e-09
|
|
REACTOME CITRIC ACID CYCLE TCA CYCLE
|
19
|
5.10e-13
|
4.64e-11
|
0.98300
|
3.91e-01
|
-0.902000
|
3.15e-03
|
9.83e-12
|
|
REACTOME RESPIRATORY ELECTRON TRANSPORT
|
59
|
1.01e-31
|
1.54e-29
|
0.89300
|
1.18e-01
|
-0.885000
|
1.16e-01
|
4.99e-32
|
|
REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
|
73
|
1.81e-38
|
4.12e-36
|
0.88300
|
1.89e-01
|
-0.863000
|
5.33e-03
|
2.31e-37
|
|
REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT
|
107
|
3.05e-52
|
1.39e-49
|
0.85200
|
2.03e-01
|
-0.827000
|
2.97e-04
|
1.04e-49
|
|
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION
|
13
|
2.72e-06
|
1.24e-04
|
0.80100
|
2.93e-01
|
-0.745000
|
6.77e-02
|
3.27e-06
|
|
REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE
|
38
|
6.77e-17
|
7.70e-15
|
0.80000
|
2.50e-01
|
-0.760000
|
7.82e-03
|
5.17e-16
|
|
REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
|
11
|
7.58e-05
|
2.15e-03
|
0.77100
|
6.13e-01
|
0.468000
|
4.30e-04
|
7.25e-03
|
|
REACTOME COMPLEMENT CASCADE
|
11
|
1.12e-04
|
3.01e-03
|
0.72900
|
-5.05e-01
|
0.526000
|
3.73e-03
|
2.51e-03
|
|
REACTOME NCAM1 INTERACTIONS
|
16
|
5.25e-06
|
2.17e-04
|
0.70600
|
-1.50e-01
|
0.690000
|
3.00e-01
|
1.74e-06
|
|
REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
|
11
|
4.18e-04
|
8.65e-03
|
0.68200
|
1.28e-01
|
-0.670000
|
4.64e-01
|
1.19e-04
|
|
REACTOME MITOCHONDRIAL PROTEIN IMPORT
|
42
|
7.29e-13
|
5.53e-11
|
0.66200
|
1.27e-01
|
-0.650000
|
1.56e-01
|
3.21e-13
|
|
REACTOME EXTRACELLULAR MATRIX ORGANIZATION
|
32
|
7.87e-10
|
4.48e-08
|
0.65300
|
-2.45e-01
|
0.605000
|
1.66e-02
|
3.11e-09
|
|
REACTOME PYRUVATE METABOLISM
|
16
|
6.86e-05
|
2.08e-03
|
0.62700
|
1.49e-01
|
-0.609000
|
3.02e-01
|
2.48e-05
|
|
REACTOME COLLAGEN FORMATION
|
27
|
1.86e-07
|
9.39e-06
|
0.61200
|
-2.12e-01
|
0.574000
|
5.71e-02
|
2.45e-07
|
|
REACTOME GLUCONEOGENESIS
|
18
|
3.36e-05
|
1.18e-03
|
0.61000
|
5.61e-01
|
-0.240000
|
3.84e-05
|
7.78e-02
|
|
REACTOME ADP SIGNALLING THROUGH P2RY1
|
11
|
7.54e-03
|
8.37e-02
|
0.55000
|
-1.64e-01
|
-0.525000
|
3.45e-01
|
2.60e-03
|
|
REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR
|
10
|
1.61e-02
|
1.59e-01
|
0.53200
|
-2.45e-01
|
-0.472000
|
1.79e-01
|
9.70e-03
|
|
REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
|
11
|
1.75e-02
|
1.68e-01
|
0.50100
|
-1.74e-01
|
-0.470000
|
3.18e-01
|
7.00e-03
|
|
REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM
|
16
|
3.84e-03
|
5.45e-02
|
0.48300
|
-4.12e-02
|
-0.481000
|
7.76e-01
|
8.64e-04
|
|
REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS
|
10
|
3.37e-02
|
2.38e-01
|
0.48100
|
-4.51e-01
|
-0.167000
|
1.36e-02
|
3.59e-01
|
|
REACTOME SIGNAL ATTENUATION
|
10
|
2.97e-02
|
2.33e-01
|
0.47700
|
-4.17e-01
|
0.232000
|
2.25e-02
|
2.04e-01
|
|
REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE
|
10
|
3.40e-02
|
2.38e-01
|
0.47500
|
1.66e-03
|
-0.475000
|
9.93e-01
|
9.37e-03
|
|
REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
|
13
|
1.85e-02
|
1.69e-01
|
0.46000
|
3.51e-01
|
0.297000
|
2.84e-02
|
6.34e-02
|
|
REACTOME G PROTEIN BETA GAMMA SIGNALLING
|
12
|
3.07e-02
|
2.33e-01
|
0.44700
|
-2.10e-01
|
-0.394000
|
2.07e-01
|
1.82e-02
|
|
REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING
|
17
|
5.77e-03
|
7.02e-02
|
0.44500
|
-4.26e-01
|
0.130000
|
2.37e-03
|
3.54e-01
|
|
REACTOME PLATELET AGGREGATION PLUG FORMATION
|
18
|
6.02e-03
|
7.02e-02
|
0.43200
|
-4.20e-01
|
0.099900
|
2.04e-03
|
4.64e-01
|
|
REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM
|
20
|
3.45e-03
|
5.07e-02
|
0.42800
|
-2.51e-01
|
0.347000
|
5.24e-02
|
7.33e-03
|
|
REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS
|
15
|
1.97e-02
|
1.72e-01
|
0.42500
|
3.33e-01
|
0.264000
|
2.55e-02
|
7.67e-02
|
|
REACTOME SIGNAL AMPLIFICATION
|
14
|
3.18e-02
|
2.33e-01
|
0.41000
|
-1.57e-01
|
-0.379000
|
3.11e-01
|
1.40e-02
|
|
REACTOME SPRY REGULATION OF FGF SIGNALING
|
12
|
4.79e-02
|
3.07e-01
|
0.41000
|
-4.09e-01
|
0.027200
|
1.42e-02
|
8.71e-01
|
|
REACTOME AQUAPORIN MEDIATED TRANSPORT
|
20
|
5.97e-03
|
7.02e-02
|
0.40900
|
1.33e-01
|
-0.387000
|
3.05e-01
|
2.76e-03
|
|
REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS
|
20
|
5.97e-03
|
7.02e-02
|
0.40900
|
1.33e-01
|
-0.387000
|
3.05e-01
|
2.76e-03
|
|
REACTOME DCC MEDIATED ATTRACTIVE SIGNALING
|
10
|
8.93e-02
|
4.58e-01
|
0.40500
|
-3.87e-01
|
-0.122000
|
3.43e-02
|
5.03e-01
|
|
REACTOME KERATAN SULFATE KERATIN METABOLISM
|
14
|
3.13e-02
|
2.33e-01
|
0.40500
|
-3.89e-02
|
0.403000
|
8.01e-01
|
9.07e-03
|
|
REACTOME METABOLISM OF PORPHYRINS
|
11
|
6.13e-02
|
3.72e-01
|
0.40400
|
2.78e-01
|
-0.293000
|
1.10e-01
|
9.21e-02
|
|
REACTOME HS GAG DEGRADATION
|
10
|
9.63e-02
|
4.72e-01
|
0.39600
|
2.67e-02
|
0.395000
|
8.84e-01
|
3.06e-02
|
|
REACTOME GPVI MEDIATED ACTIVATION CASCADE
|
16
|
2.26e-02
|
1.83e-01
|
0.39500
|
-3.90e-01
|
0.066600
|
7.00e-03
|
6.45e-01
|
|
REACTOME KERATAN SULFATE BIOSYNTHESIS
|
11
|
7.57e-02
|
4.22e-01
|
0.39300
|
-6.29e-02
|
0.388000
|
7.18e-01
|
2.58e-02
|
|
REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION
|
15
|
3.30e-02
|
2.38e-01
|
0.38400
|
1.83e-01
|
-0.337000
|
2.19e-01
|
2.38e-02
|
|
REACTOME G PROTEIN ACTIVATION
|
10
|
1.14e-01
|
4.98e-01
|
0.38000
|
8.70e-03
|
-0.380000
|
9.62e-01
|
3.74e-02
|
|
REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
|
13
|
5.51e-02
|
3.48e-01
|
0.37900
|
-2.54e-01
|
0.281000
|
1.13e-01
|
7.93e-02
|
|
REACTOME NEGATIVE REGULATION OF FGFR SIGNALING
|
16
|
3.58e-02
|
2.43e-01
|
0.37200
|
-3.71e-01
|
0.027200
|
1.03e-02
|
8.50e-01
|
|
REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS
|
14
|
6.76e-02
|
4.01e-01
|
0.36400
|
-2.03e-01
|
-0.302000
|
1.88e-01
|
5.03e-02
|
|
REACTOME DOUBLE STRAND BREAK REPAIR
|
12
|
1.07e-01
|
4.84e-01
|
0.35800
|
3.01e-01
|
0.194000
|
7.08e-02
|
2.45e-01
|
|
REACTOME INTEGRIN CELL SURFACE INTERACTIONS
|
40
|
4.07e-04
|
8.65e-03
|
0.35500
|
-2.80e-01
|
0.218000
|
2.20e-03
|
1.69e-02
|
|
REACTOME METABOLISM OF POLYAMINES
|
11
|
1.22e-01
|
5.10e-01
|
0.35400
|
3.43e-01
|
-0.086600
|
4.88e-02
|
6.19e-01
|
|
REACTOME GLUCOSE METABOLISM
|
43
|
3.31e-04
|
7.53e-03
|
0.35200
|
3.50e-01
|
-0.033800
|
7.21e-05
|
7.02e-01
|
|
REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
|
11
|
1.26e-01
|
5.17e-01
|
0.35100
|
3.41e-01
|
-0.084400
|
5.02e-02
|
6.28e-01
|
|
REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING
|
10
|
1.54e-01
|
5.55e-01
|
0.35100
|
7.42e-02
|
-0.343000
|
6.85e-01
|
6.08e-02
|
|
REACTOME GLYCOSAMINOGLYCAN METABOLISM
|
45
|
2.37e-04
|
5.83e-03
|
0.35000
|
-5.10e-02
|
0.347000
|
5.54e-01
|
5.81e-05
|
|
REACTOME CTLA4 INHIBITORY SIGNALING
|
15
|
7.73e-02
|
4.22e-01
|
0.34100
|
-3.25e-01
|
-0.101000
|
2.91e-02
|
4.99e-01
|
|
REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH
|
35
|
2.22e-03
|
3.74e-02
|
0.33900
|
-8.23e-02
|
0.329000
|
4.00e-01
|
7.75e-04
|
|
REACTOME REGULATION OF SIGNALING BY CBL
|
13
|
1.17e-01
|
4.98e-01
|
0.33600
|
-3.08e-01
|
-0.135000
|
5.48e-02
|
4.00e-01
|
|
REACTOME LIPOPROTEIN METABOLISM
|
11
|
1.48e-01
|
5.55e-01
|
0.33500
|
-1.75e-01
|
0.286000
|
3.16e-01
|
1.01e-01
|
|
REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM
|
23
|
1.96e-02
|
1.72e-01
|
0.33300
|
-1.55e-01
|
0.295000
|
1.98e-01
|
1.45e-02
|
|
REACTOME MITOCHONDRIAL TRNA AMINOACYLATION
|
20
|
3.51e-02
|
2.42e-01
|
0.33200
|
3.27e-01
|
-0.057300
|
1.13e-02
|
6.57e-01
|
|
REACTOME GLUTATHIONE CONJUGATION
|
12
|
1.35e-01
|
5.43e-01
|
0.33200
|
3.28e-01
|
-0.050000
|
4.93e-02
|
7.65e-01
|
|
REACTOME SYNTHESIS OF PA
|
10
|
1.91e-01
|
6.14e-01
|
0.32700
|
1.60e-01
|
-0.285000
|
3.80e-01
|
1.19e-01
|
|
REACTOME STRIATED MUSCLE CONTRACTION
|
22
|
2.95e-02
|
2.33e-01
|
0.32700
|
1.03e-02
|
-0.326000
|
9.34e-01
|
8.09e-03
|
|
REACTOME FATTY ACYL COA BIOSYNTHESIS
|
10
|
1.95e-01
|
6.14e-01
|
0.32500
|
-2.29e-01
|
0.230000
|
2.09e-01
|
2.09e-01
|
|
REACTOME SIGNALING BY NODAL
|
11
|
1.98e-01
|
6.14e-01
|
0.31500
|
5.84e-02
|
0.310000
|
7.37e-01
|
7.55e-02
|
|
REACTOME RNA POL I TRANSCRIPTION TERMINATION
|
19
|
5.61e-02
|
3.49e-01
|
0.31400
|
2.94e-01
|
-0.111000
|
2.64e-02
|
4.03e-01
|
|
REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT
|
21
|
4.26e-02
|
2.77e-01
|
0.31400
|
-3.06e-01
|
0.070000
|
1.51e-02
|
5.79e-01
|
|
REACTOME TIE2 SIGNALING
|
13
|
1.56e-01
|
5.55e-01
|
0.31400
|
-2.63e-01
|
-0.171000
|
1.01e-01
|
2.86e-01
|
|
REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY
|
11
|
1.89e-01
|
6.14e-01
|
0.31300
|
-2.77e-01
|
0.146000
|
1.11e-01
|
4.02e-01
|
|
REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION
|
28
|
2.14e-02
|
1.77e-01
|
0.30800
|
2.44e-01
|
0.188000
|
2.53e-02
|
8.61e-02
|
|
REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION
|
83
|
1.03e-05
|
3.92e-04
|
0.30700
|
-7.63e-02
|
-0.298000
|
2.31e-01
|
2.89e-06
|
|
REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES
|
14
|
1.34e-01
|
5.43e-01
|
0.30400
|
1.98e-01
|
-0.231000
|
2.00e-01
|
1.34e-01
|
|
REACTOME ION CHANNEL TRANSPORT
|
18
|
8.58e-02
|
4.49e-01
|
0.30400
|
-2.96e-01
|
-0.067800
|
2.96e-02
|
6.19e-01
|
|
REACTOME SIGNALING BY NOTCH3
|
10
|
2.77e-01
|
7.34e-01
|
0.29700
|
-1.63e-01
|
-0.249000
|
3.73e-01
|
1.73e-01
|
|
REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
|
14
|
1.68e-01
|
5.88e-01
|
0.29600
|
2.56e-01
|
0.148000
|
9.68e-02
|
3.38e-01
|
|
REACTOME PEPTIDE CHAIN ELONGATION
|
67
|
2.43e-04
|
5.83e-03
|
0.29300
|
-1.34e-01
|
-0.260000
|
5.90e-02
|
2.34e-04
|
|
REACTOME MYOGENESIS
|
21
|
6.78e-02
|
4.01e-01
|
0.29200
|
-2.65e-02
|
0.290000
|
8.33e-01
|
2.13e-02
|
|
REACTOME G ALPHA Z SIGNALLING EVENTS
|
20
|
7.32e-02
|
4.22e-01
|
0.29000
|
1.98e-01
|
-0.213000
|
1.26e-01
|
9.97e-02
|
|
REACTOME ION TRANSPORT BY P TYPE ATPASES
|
17
|
1.25e-01
|
5.17e-01
|
0.28800
|
-2.79e-01
|
-0.070800
|
4.64e-02
|
6.14e-01
|
|
REACTOME VIRAL MESSENGER RNA SYNTHESIS
|
14
|
1.72e-01
|
5.89e-01
|
0.28500
|
1.35e-01
|
-0.252000
|
3.83e-01
|
1.03e-01
|
|
REACTOME TRAFFICKING OF AMPA RECEPTORS
|
15
|
1.64e-01
|
5.80e-01
|
0.28500
|
5.36e-02
|
0.280000
|
7.19e-01
|
6.05e-02
|
|
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
|
18
|
1.15e-01
|
4.98e-01
|
0.28400
|
-2.82e-01
|
-0.035100
|
3.82e-02
|
7.96e-01
|
|
REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS
|
14
|
1.84e-01
|
6.14e-01
|
0.28300
|
2.98e-02
|
-0.281000
|
8.47e-01
|
6.84e-02
|
|
REACTOME TRNA AMINOACYLATION
|
39
|
9.08e-03
|
9.38e-02
|
0.28200
|
2.79e-01
|
-0.041700
|
2.56e-03
|
6.52e-01
|
|
REACTOME CYTOSOLIC TRNA AMINOACYLATION
|
22
|
7.54e-02
|
4.22e-01
|
0.28200
|
2.74e-01
|
0.069900
|
2.64e-02
|
5.70e-01
|
|
REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK
|
10
|
3.04e-01
|
7.68e-01
|
0.28100
|
-3.16e-02
|
0.279000
|
8.63e-01
|
1.27e-01
|
|
REACTOME HS GAG BIOSYNTHESIS
|
14
|
2.12e-01
|
6.39e-01
|
0.27600
|
1.21e-01
|
0.247000
|
4.32e-01
|
1.09e-01
|
|
REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA
|
11
|
2.78e-01
|
7.34e-01
|
0.27500
|
-2.42e-01
|
0.130000
|
1.65e-01
|
4.56e-01
|
|
REACTOME O LINKED GLYCOSYLATION OF MUCINS
|
10
|
3.36e-01
|
7.95e-01
|
0.27400
|
1.68e-01
|
0.217000
|
3.57e-01
|
2.35e-01
|
|
REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
|
43
|
8.12e-03
|
8.80e-02
|
0.27400
|
-2.73e-01
|
-0.022700
|
1.94e-03
|
7.97e-01
|
|
REACTOME SEMA3A PAK DEPENDENT AXON REPULSION
|
10
|
3.36e-01
|
7.95e-01
|
0.27400
|
-2.39e-01
|
-0.134000
|
1.91e-01
|
4.63e-01
|
|
REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
|
13
|
2.34e-01
|
6.86e-01
|
0.27300
|
2.73e-01
|
-0.005890
|
8.86e-02
|
9.71e-01
|
|
REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC
|
19
|
1.15e-01
|
4.98e-01
|
0.27300
|
2.57e-01
|
-0.092100
|
5.29e-02
|
4.87e-01
|
|
REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION
|
15
|
2.08e-01
|
6.36e-01
|
0.26900
|
-2.05e-01
|
-0.174000
|
1.69e-01
|
2.44e-01
|
|
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
|
12
|
2.62e-01
|
7.18e-01
|
0.26900
|
-2.27e-01
|
0.144000
|
1.74e-01
|
3.88e-01
|
|
REACTOME EGFR DOWNREGULATION
|
23
|
8.20e-02
|
4.34e-01
|
0.26500
|
-1.38e-01
|
0.226000
|
2.51e-01
|
6.04e-02
|
|
REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS
|
11
|
3.18e-01
|
7.88e-01
|
0.26500
|
-2.62e-01
|
-0.041400
|
1.33e-01
|
8.12e-01
|
|
REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA
|
13
|
2.57e-01
|
7.11e-01
|
0.26400
|
1.04e-02
|
-0.263000
|
9.48e-01
|
1.00e-01
|
|
REACTOME GLYCOLYSIS
|
19
|
1.44e-01
|
5.52e-01
|
0.26300
|
2.50e-01
|
0.084700
|
5.99e-02
|
5.23e-01
|
|
REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY
|
22
|
9.99e-02
|
4.76e-01
|
0.26200
|
-7.01e-02
|
0.252000
|
5.70e-01
|
4.05e-02
|
|
REACTOME MICRORNA MIRNA BIOGENESIS
|
18
|
1.49e-01
|
5.55e-01
|
0.26200
|
2.24e-01
|
-0.134000
|
9.97e-02
|
3.24e-01
|
|
REACTOME EXTENSION OF TELOMERES
|
13
|
2.55e-01
|
7.11e-01
|
0.26100
|
2.35e-01
|
-0.113000
|
1.42e-01
|
4.80e-01
|
|
REACTOME TRAF6 MEDIATED NFKB ACTIVATION
|
13
|
2.79e-01
|
7.34e-01
|
0.26000
|
-2.08e-01
|
-0.157000
|
1.94e-01
|
3.28e-01
|
|
REACTOME PROLONGED ERK ACTIVATION EVENTS
|
16
|
1.98e-01
|
6.14e-01
|
0.25900
|
-2.58e-01
|
0.023100
|
7.41e-02
|
8.73e-01
|
|
REACTOME CHOLESTEROL BIOSYNTHESIS
|
11
|
3.51e-01
|
7.95e-01
|
0.25700
|
-1.98e-01
|
-0.163000
|
2.56e-01
|
3.49e-01
|
|
REACTOME PURINE METABOLISM
|
25
|
8.95e-02
|
4.58e-01
|
0.25000
|
2.17e-01
|
-0.124000
|
6.05e-02
|
2.83e-01
|
|
REACTOME ACTIVATION OF BH3 ONLY PROTEINS
|
10
|
4.11e-01
|
8.04e-01
|
0.24800
|
-1.99e-01
|
-0.147000
|
2.76e-01
|
4.20e-01
|
|
REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS
|
21
|
1.51e-01
|
5.55e-01
|
0.24600
|
2.19e-02
|
0.245000
|
8.62e-01
|
5.23e-02
|
|
REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION
|
18
|
1.90e-01
|
6.14e-01
|
0.24500
|
-8.89e-02
|
0.229000
|
5.14e-01
|
9.33e-02
|
|
REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS
|
22
|
1.37e-01
|
5.43e-01
|
0.24400
|
-4.86e-02
|
0.239000
|
6.93e-01
|
5.24e-02
|
|
REACTOME PEROXISOMAL LIPID METABOLISM
|
16
|
2.50e-01
|
7.08e-01
|
0.24400
|
-1.01e-01
|
-0.222000
|
4.85e-01
|
1.25e-01
|
|
REACTOME PLATELET HOMEOSTASIS
|
32
|
5.76e-02
|
3.54e-01
|
0.24300
|
4.21e-02
|
-0.239000
|
6.81e-01
|
1.94e-02
|
|
REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1
|
19
|
1.97e-01
|
6.14e-01
|
0.23900
|
-2.02e-02
|
-0.239000
|
8.79e-01
|
7.20e-02
|
|
REACTOME ERKS ARE INACTIVATED
|
10
|
4.21e-01
|
8.12e-01
|
0.23900
|
-2.38e-01
|
0.027400
|
1.93e-01
|
8.81e-01
|
|
REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS
|
21
|
1.71e-01
|
5.89e-01
|
0.23900
|
-6.39e-02
|
-0.230000
|
6.12e-01
|
6.77e-02
|
|
REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION
|
86
|
7.22e-04
|
1.31e-02
|
0.23900
|
-3.97e-02
|
-0.236000
|
5.25e-01
|
1.63e-04
|
|
REACTOME ENOS ACTIVATION AND REGULATION
|
12
|
3.66e-01
|
7.95e-01
|
0.23900
|
-2.28e-01
|
-0.071600
|
1.72e-01
|
6.68e-01
|
|
REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
|
89
|
6.79e-04
|
1.29e-02
|
0.23800
|
-1.04e-01
|
-0.214000
|
9.22e-02
|
4.92e-04
|
|
REACTOME MITOTIC G2 G2 M PHASES
|
49
|
1.81e-02
|
1.68e-01
|
0.23800
|
2.10e-01
|
0.110000
|
1.09e-02
|
1.83e-01
|
|
REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES
|
43
|
3.09e-02
|
2.33e-01
|
0.23600
|
2.07e-01
|
0.114000
|
1.92e-02
|
1.95e-01
|
|
REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS
|
22
|
1.56e-01
|
5.55e-01
|
0.23600
|
2.33e-01
|
-0.039600
|
5.90e-02
|
7.48e-01
|
|
REACTOME METAL ION SLC TRANSPORTERS
|
12
|
3.80e-01
|
7.95e-01
|
0.23600
|
-1.40e-01
|
-0.190000
|
4.01e-01
|
2.55e-01
|
|
REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX
|
16
|
2.79e-01
|
7.34e-01
|
0.23500
|
-1.30e-01
|
-0.195000
|
3.68e-01
|
1.77e-01
|
|
REACTOME RAP1 SIGNALLING
|
12
|
3.80e-01
|
7.95e-01
|
0.23400
|
-2.22e-01
|
-0.074400
|
1.83e-01
|
6.56e-01
|
|
REACTOME MHC CLASS II ANTIGEN PRESENTATION
|
60
|
9.34e-03
|
9.44e-02
|
0.23000
|
5.77e-02
|
0.223000
|
4.41e-01
|
2.85e-03
|
|
REACTOME PROCESSING OF INTRONLESS PRE MRNAS
|
13
|
3.59e-01
|
7.95e-01
|
0.23000
|
-1.84e-02
|
-0.229000
|
9.08e-01
|
1.52e-01
|
|
REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES
|
25
|
1.37e-01
|
5.43e-01
|
0.22900
|
-2.25e-01
|
0.040100
|
5.12e-02
|
7.29e-01
|
|
REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX
|
85
|
1.56e-03
|
2.73e-02
|
0.22900
|
-8.90e-02
|
-0.211000
|
1.57e-01
|
7.98e-04
|
|
REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN
|
21
|
1.93e-01
|
6.14e-01
|
0.22500
|
-1.34e-01
|
0.181000
|
2.88e-01
|
1.52e-01
|
|
REACTOME METABOLISM OF VITAMINS AND COFACTORS
|
35
|
7.68e-02
|
4.22e-01
|
0.22500
|
-1.08e-01
|
-0.197000
|
2.69e-01
|
4.39e-02
|
|
REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI
|
13
|
3.90e-01
|
7.95e-01
|
0.22400
|
-1.62e-01
|
-0.155000
|
3.13e-01
|
3.34e-01
|
|
REACTOME SIGNALING BY NOTCH2
|
10
|
4.85e-01
|
8.51e-01
|
0.22400
|
-1.52e-01
|
-0.164000
|
4.06e-01
|
3.69e-01
|
|
REACTOME INWARDLY RECTIFYING K CHANNELS
|
10
|
4.78e-01
|
8.46e-01
|
0.22400
|
-4.48e-02
|
-0.219000
|
8.06e-01
|
2.31e-01
|
|
REACTOME GABA B RECEPTOR ACTIVATION
|
13
|
3.73e-01
|
7.95e-01
|
0.22300
|
4.16e-02
|
-0.220000
|
7.95e-01
|
1.71e-01
|
|
REACTOME PRE NOTCH EXPRESSION AND PROCESSING
|
31
|
9.15e-02
|
4.63e-01
|
0.22300
|
-1.33e-01
|
0.179000
|
2.00e-01
|
8.42e-02
|
|
REACTOME DAG AND IP3 SIGNALING
|
15
|
3.39e-01
|
7.95e-01
|
0.22300
|
1.71e-01
|
0.143000
|
2.51e-01
|
3.37e-01
|
|
REACTOME NEPHRIN INTERACTIONS
|
14
|
3.64e-01
|
7.95e-01
|
0.22300
|
-1.14e-01
|
-0.192000
|
4.61e-01
|
2.15e-01
|
|
REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1
|
13
|
3.94e-01
|
7.95e-01
|
0.22300
|
-1.48e-01
|
-0.166000
|
3.55e-01
|
3.00e-01
|
|
REACTOME EFFECTS OF PIP2 HYDROLYSIS
|
13
|
3.96e-01
|
7.95e-01
|
0.22200
|
1.63e-01
|
0.151000
|
3.09e-01
|
3.47e-01
|
|
REACTOME APOPTOTIC EXECUTION PHASE
|
27
|
1.48e-01
|
5.55e-01
|
0.22100
|
1.22e-01
|
0.184000
|
2.71e-01
|
9.80e-02
|
|
REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT
|
19
|
2.42e-01
|
6.94e-01
|
0.22000
|
1.04e-01
|
-0.194000
|
4.35e-01
|
1.43e-01
|
|
REACTOME CELL CELL JUNCTION ORGANIZATION
|
13
|
3.82e-01
|
7.95e-01
|
0.21900
|
-1.00e-01
|
0.195000
|
5.32e-01
|
2.23e-01
|
|
REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA
|
19
|
2.58e-01
|
7.11e-01
|
0.21900
|
-2.69e-02
|
-0.217000
|
8.39e-01
|
1.01e-01
|
|
REACTOME DEADENYLATION OF MRNA
|
16
|
3.09e-01
|
7.69e-01
|
0.21900
|
2.05e-01
|
-0.075400
|
1.55e-01
|
6.02e-01
|
|
REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION
|
14
|
3.67e-01
|
7.95e-01
|
0.21900
|
6.25e-05
|
-0.219000
|
1.00e+00
|
1.57e-01
|
|
REACTOME VOLTAGE GATED POTASSIUM CHANNELS
|
10
|
4.78e-01
|
8.46e-01
|
0.21800
|
1.49e-01
|
-0.160000
|
4.15e-01
|
3.83e-01
|
|
REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
31
|
1.16e-01
|
4.98e-01
|
0.21600
|
2.74e-02
|
0.215000
|
7.92e-01
|
3.87e-02
|
|
REACTOME INTRINSIC PATHWAY FOR APOPTOSIS
|
16
|
3.49e-01
|
7.95e-01
|
0.21300
|
-1.60e-01
|
-0.141000
|
2.68e-01
|
3.28e-01
|
|
REACTOME DESTABILIZATION OF MRNA BY KSRP
|
14
|
3.78e-01
|
7.95e-01
|
0.21200
|
9.60e-02
|
-0.189000
|
5.34e-01
|
2.20e-01
|
|
REACTOME GPCR LIGAND BINDING
|
40
|
7.70e-02
|
4.22e-01
|
0.21000
|
-1.77e-01
|
-0.114000
|
5.34e-02
|
2.12e-01
|
|
REACTOME FORMATION OF INCISION COMPLEX IN GG NER
|
16
|
3.51e-01
|
7.95e-01
|
0.20900
|
2.09e-01
|
0.006650
|
1.48e-01
|
9.63e-01
|
|
REACTOME G ALPHA S SIGNALLING EVENTS
|
26
|
1.80e-01
|
6.11e-01
|
0.20700
|
1.05e-01
|
-0.178000
|
3.56e-01
|
1.16e-01
|
|
REACTOME LYSOSOME VESICLE BIOGENESIS
|
17
|
3.40e-01
|
7.95e-01
|
0.20600
|
1.23e-02
|
0.206000
|
9.30e-01
|
1.42e-01
|
|
REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP
|
16
|
3.52e-01
|
7.95e-01
|
0.20600
|
9.31e-02
|
-0.184000
|
5.19e-01
|
2.04e-01
|
|
REACTOME GABA RECEPTOR ACTIVATION
|
14
|
4.14e-01
|
8.05e-01
|
0.20500
|
-3.47e-03
|
-0.205000
|
9.82e-01
|
1.84e-01
|
|
REACTOME CIRCADIAN CLOCK
|
42
|
7.89e-02
|
4.22e-01
|
0.20400
|
9.32e-02
|
0.182000
|
2.97e-01
|
4.21e-02
|
|
REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES
|
38
|
1.01e-01
|
4.76e-01
|
0.20400
|
1.74e-01
|
0.107000
|
6.41e-02
|
2.56e-01
|
|
REACTOME RNA POL I TRANSCRIPTION INITIATION
|
23
|
2.38e-01
|
6.89e-01
|
0.20300
|
2.00e-01
|
-0.036000
|
9.74e-02
|
7.65e-01
|
|
REACTOME BIOLOGICAL OXIDATIONS
|
37
|
9.54e-02
|
4.72e-01
|
0.20300
|
1.07e-01
|
-0.172000
|
2.60e-01
|
7.02e-02
|
|
REACTOME SMOOTH MUSCLE CONTRACTION
|
19
|
3.04e-01
|
7.68e-01
|
0.20200
|
1.88e-01
|
-0.074900
|
1.57e-01
|
5.72e-01
|
|
REACTOME POTASSIUM CHANNELS
|
21
|
2.78e-01
|
7.34e-01
|
0.19900
|
9.12e-02
|
-0.177000
|
4.70e-01
|
1.61e-01
|
|
REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES
|
31
|
1.72e-01
|
5.89e-01
|
0.19800
|
1.47e-01
|
0.134000
|
1.58e-01
|
1.99e-01
|
|
REACTOME G1 PHASE
|
25
|
2.26e-01
|
6.68e-01
|
0.19600
|
-1.73e-01
|
0.092900
|
1.35e-01
|
4.22e-01
|
|
REACTOME CELL JUNCTION ORGANIZATION
|
26
|
2.14e-01
|
6.42e-01
|
0.19600
|
-1.76e-01
|
0.085800
|
1.20e-01
|
4.49e-01
|
|
REACTOME MUSCLE CONTRACTION
|
37
|
1.14e-01
|
4.98e-01
|
0.19500
|
1.10e-01
|
-0.161000
|
2.48e-01
|
9.05e-02
|
|
REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES
|
103
|
2.61e-03
|
4.10e-02
|
0.19400
|
1.19e-01
|
-0.153000
|
3.78e-02
|
7.40e-03
|
|
REACTOME SIGNALING BY ROBO RECEPTOR
|
19
|
3.59e-01
|
7.95e-01
|
0.19100
|
2.72e-02
|
0.189000
|
8.38e-01
|
1.55e-01
|
|
REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION
|
57
|
4.22e-02
|
2.77e-01
|
0.19000
|
-1.68e-01
|
0.089400
|
2.87e-02
|
2.44e-01
|
|
REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX
|
28
|
2.10e-01
|
6.37e-01
|
0.19000
|
1.06e-01
|
-0.157000
|
3.31e-01
|
1.50e-01
|
|
REACTOME GLOBAL GENOMIC NER GG NER
|
22
|
3.08e-01
|
7.69e-01
|
0.18900
|
1.89e-01
|
0.009140
|
1.25e-01
|
9.41e-01
|
|
REACTOME BOTULINUM NEUROTOXICITY
|
10
|
5.88e-01
|
8.98e-01
|
0.18800
|
-1.88e-01
|
-0.001900
|
3.03e-01
|
9.92e-01
|
|
REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS
|
10
|
5.88e-01
|
8.98e-01
|
0.18800
|
-1.88e-01
|
-0.001900
|
3.03e-01
|
9.92e-01
|
|
REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S
|
38
|
1.42e-01
|
5.52e-01
|
0.18700
|
5.19e-02
|
0.180000
|
5.80e-01
|
5.56e-02
|
|
REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX
|
42
|
1.07e-01
|
4.84e-01
|
0.18700
|
4.71e-02
|
-0.181000
|
5.98e-01
|
4.28e-02
|
|
REACTOME TOLL RECEPTOR CASCADES
|
72
|
2.11e-02
|
1.77e-01
|
0.18700
|
-1.53e-01
|
0.106000
|
2.48e-02
|
1.19e-01
|
|
REACTOME PHASE II CONJUGATION
|
23
|
2.90e-01
|
7.47e-01
|
0.18700
|
1.54e-01
|
-0.105000
|
2.01e-01
|
3.83e-01
|
|
REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR
|
10
|
6.12e-01
|
9.02e-01
|
0.18400
|
-1.62e-01
|
-0.085800
|
3.74e-01
|
6.38e-01
|
|
REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION
|
106
|
5.41e-03
|
7.02e-02
|
0.18200
|
-1.82e-01
|
-0.007360
|
1.23e-03
|
8.96e-01
|
|
REACTOME PRE NOTCH PROCESSING IN GOLGI
|
14
|
4.86e-01
|
8.51e-01
|
0.18200
|
-1.08e-01
|
0.147000
|
4.85e-01
|
3.41e-01
|
|
REACTOME PHOSPHOLIPASE C MEDIATED CASCADE
|
18
|
4.21e-01
|
8.12e-01
|
0.18200
|
1.39e-01
|
0.118000
|
3.08e-01
|
3.87e-01
|
|
REACTOME COSTIMULATION BY THE CD28 FAMILY
|
34
|
1.92e-01
|
6.14e-01
|
0.18000
|
-1.80e-01
|
-0.000180
|
6.95e-02
|
9.99e-01
|
|
REACTOME METABOLISM OF CARBOHYDRATES
|
124
|
3.23e-03
|
4.90e-02
|
0.17900
|
8.48e-02
|
0.158000
|
1.04e-01
|
2.47e-03
|
|
REACTOME MEIOTIC SYNAPSIS
|
15
|
4.77e-01
|
8.46e-01
|
0.17900
|
-1.65e-01
|
0.068900
|
2.68e-01
|
6.44e-01
|
|
REACTOME MRNA CAPPING
|
28
|
2.52e-01
|
7.08e-01
|
0.17900
|
8.22e-02
|
-0.159000
|
4.52e-01
|
1.46e-01
|
|
REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR
|
17
|
4.37e-01
|
8.21e-01
|
0.17900
|
-1.72e-01
|
0.049300
|
2.21e-01
|
7.25e-01
|
|
REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING
|
20
|
3.84e-01
|
7.95e-01
|
0.17800
|
1.78e-01
|
-0.010700
|
1.69e-01
|
9.34e-01
|
|
REACTOME ARMS MEDIATED ACTIVATION
|
14
|
5.14e-01
|
8.66e-01
|
0.17800
|
-1.78e-01
|
-0.001810
|
2.49e-01
|
9.91e-01
|
|
REACTOME P38MAPK EVENTS
|
10
|
6.13e-01
|
9.02e-01
|
0.17800
|
9.94e-02
|
-0.147000
|
5.86e-01
|
4.20e-01
|
|
REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT
|
16
|
4.81e-01
|
8.49e-01
|
0.17700
|
1.53e-01
|
0.090500
|
2.91e-01
|
5.31e-01
|
|
REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE
|
15
|
4.91e-01
|
8.55e-01
|
0.17600
|
1.67e-01
|
-0.054600
|
2.62e-01
|
7.15e-01
|
|
REACTOME SIGNALLING TO P38 VIA RIT AND RIN
|
11
|
6.08e-01
|
9.02e-01
|
0.17600
|
6.24e-02
|
0.164000
|
7.20e-01
|
3.45e-01
|
|
REACTOME SULFUR AMINO ACID METABOLISM
|
17
|
4.52e-01
|
8.36e-01
|
0.17600
|
1.73e-01
|
-0.029400
|
2.17e-01
|
8.34e-01
|
|
REACTOME REGULATORY RNA PATHWAYS
|
21
|
3.77e-01
|
7.95e-01
|
0.17500
|
1.74e-01
|
-0.022100
|
1.68e-01
|
8.61e-01
|
|
REACTOME GLUCOSE TRANSPORT
|
27
|
2.78e-01
|
7.34e-01
|
0.17500
|
-1.10e-01
|
0.136000
|
3.23e-01
|
2.21e-01
|
|
REACTOME INFLUENZA LIFE CYCLE
|
112
|
6.99e-03
|
7.95e-02
|
0.17500
|
-6.08e-02
|
-0.164000
|
2.68e-01
|
2.82e-03
|
|
REACTOME CELL CELL COMMUNICATION
|
50
|
1.00e-01
|
4.76e-01
|
0.17500
|
-1.73e-01
|
0.021800
|
3.43e-02
|
7.90e-01
|
|
REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
|
49
|
1.05e-01
|
4.84e-01
|
0.17400
|
5.42e-02
|
-0.165000
|
5.12e-01
|
4.58e-02
|
|
REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS
|
15
|
5.12e-01
|
8.66e-01
|
0.17100
|
-6.14e-02
|
0.159000
|
6.81e-01
|
2.86e-01
|
|
REACTOME G ALPHA I SIGNALLING EVENTS
|
28
|
3.06e-01
|
7.68e-01
|
0.17000
|
-5.37e-02
|
-0.161000
|
6.23e-01
|
1.40e-01
|
|
REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN
|
22
|
3.79e-01
|
7.95e-01
|
0.17000
|
-5.62e-02
|
0.160000
|
6.48e-01
|
1.94e-01
|
|
REACTOME TRANSLATION
|
124
|
5.74e-03
|
7.02e-02
|
0.17000
|
-6.00e-02
|
-0.159000
|
2.51e-01
|
2.38e-03
|
|
REACTOME AXON GUIDANCE
|
141
|
2.41e-03
|
3.92e-02
|
0.16900
|
-3.40e-02
|
0.165000
|
4.88e-01
|
7.36e-04
|
|
REACTOME NETRIN1 SIGNALING
|
21
|
4.11e-01
|
8.04e-01
|
0.16800
|
-1.68e-01
|
0.007310
|
1.83e-01
|
9.54e-01
|
|
REACTOME SIGNALING BY NOTCH4
|
10
|
6.65e-01
|
9.09e-01
|
0.16800
|
-8.95e-02
|
-0.142000
|
6.24e-01
|
4.37e-01
|
|
REACTOME DEVELOPMENTAL BIOLOGY
|
235
|
5.52e-05
|
1.80e-03
|
0.16700
|
-5.64e-02
|
0.157000
|
1.39e-01
|
3.80e-05
|
|
REACTOME DOWNSTREAM TCR SIGNALING
|
20
|
4.57e-01
|
8.36e-01
|
0.16400
|
-9.83e-02
|
-0.132000
|
4.47e-01
|
3.08e-01
|
|
REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION
|
21
|
4.40e-01
|
8.25e-01
|
0.16400
|
1.29e-01
|
0.102000
|
3.07e-01
|
4.19e-01
|
|
REACTOME IL 3 5 AND GM CSF SIGNALING
|
24
|
3.97e-01
|
7.95e-01
|
0.16300
|
-9.42e-02
|
-0.133000
|
4.25e-01
|
2.59e-01
|
|
REACTOME PLATELET SENSITIZATION BY LDL
|
11
|
6.54e-01
|
9.09e-01
|
0.16300
|
-7.57e-02
|
-0.144000
|
6.64e-01
|
4.07e-01
|
|
REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS
|
20
|
4.65e-01
|
8.36e-01
|
0.16300
|
-1.27e-01
|
-0.102000
|
3.26e-01
|
4.31e-01
|
|
REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS
|
15
|
5.49e-01
|
8.87e-01
|
0.16200
|
-1.58e-01
|
0.037100
|
2.91e-01
|
8.04e-01
|
|
REACTOME INNATE IMMUNE SYSTEM
|
118
|
8.74e-03
|
9.25e-02
|
0.16200
|
-1.29e-01
|
0.098200
|
1.61e-02
|
6.65e-02
|
|
REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS
|
15
|
5.55e-01
|
8.89e-01
|
0.16100
|
1.60e-01
|
-0.021500
|
2.85e-01
|
8.85e-01
|
|
REACTOME ACTIVATED TLR4 SIGNALLING
|
59
|
9.80e-02
|
4.74e-01
|
0.16100
|
-1.56e-01
|
0.041800
|
3.92e-02
|
5.79e-01
|
|
REACTOME CD28 CO STIMULATION
|
22
|
4.30e-01
|
8.15e-01
|
0.16100
|
-1.58e-01
|
-0.028500
|
1.99e-01
|
8.17e-01
|
|
REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION
|
52
|
1.44e-01
|
5.52e-01
|
0.16100
|
1.17e-01
|
0.111000
|
1.46e-01
|
1.67e-01
|
|
REACTOME SIGNALING BY FGFR MUTANTS
|
25
|
3.77e-01
|
7.95e-01
|
0.16100
|
-1.60e-01
|
0.015000
|
1.66e-01
|
8.97e-01
|
|
REACTOME RNA POL I TRANSCRIPTION
|
26
|
3.64e-01
|
7.95e-01
|
0.16100
|
1.60e-01
|
-0.016300
|
1.59e-01
|
8.86e-01
|
|
REACTOME TCR SIGNALING
|
27
|
3.59e-01
|
7.95e-01
|
0.16000
|
-1.58e-01
|
-0.022500
|
1.55e-01
|
8.40e-01
|
|
REACTOME BASIGIN INTERACTIONS
|
13
|
6.02e-01
|
9.02e-01
|
0.16000
|
-1.52e-01
|
0.049900
|
3.43e-01
|
7.55e-01
|
|
REACTOME CD28 DEPENDENT PI3K AKT SIGNALING
|
16
|
5.52e-01
|
8.87e-01
|
0.15900
|
-5.56e-02
|
-0.149000
|
7.00e-01
|
3.02e-01
|
|
REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS
|
42
|
2.03e-01
|
6.25e-01
|
0.15900
|
4.40e-03
|
-0.159000
|
9.61e-01
|
7.49e-02
|
|
REACTOME SIGNAL TRANSDUCTION BY L1
|
28
|
3.38e-01
|
7.95e-01
|
0.15800
|
-8.67e-02
|
0.132000
|
4.27e-01
|
2.26e-01
|
|
REACTOME GLYCOSPHINGOLIPID METABOLISM
|
19
|
4.98e-01
|
8.61e-01
|
0.15800
|
4.52e-02
|
0.151000
|
7.33e-01
|
2.53e-01
|
|
REACTOME SPHINGOLIPID METABOLISM
|
34
|
2.89e-01
|
7.47e-01
|
0.15700
|
3.26e-02
|
0.154000
|
7.43e-01
|
1.21e-01
|
|
REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS
|
15
|
5.76e-01
|
8.98e-01
|
0.15700
|
1.65e-02
|
0.156000
|
9.12e-01
|
2.94e-01
|
|
REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM
|
46
|
1.85e-01
|
6.14e-01
|
0.15600
|
-8.69e-03
|
0.156000
|
9.19e-01
|
6.72e-02
|
|
REACTOME SIGNALING BY PDGF
|
85
|
4.22e-02
|
2.77e-01
|
0.15600
|
-6.06e-02
|
0.144000
|
3.35e-01
|
2.21e-02
|
|
REACTOME SIGNALLING TO ERKS
|
28
|
3.62e-01
|
7.95e-01
|
0.15600
|
-1.56e-01
|
-0.006900
|
1.54e-01
|
9.50e-01
|
|
REACTOME TRIF MEDIATED TLR3 SIGNALING
|
52
|
1.52e-01
|
5.55e-01
|
0.15500
|
-1.54e-01
|
0.014500
|
5.44e-02
|
8.56e-01
|
|
REACTOME TELOMERE MAINTENANCE
|
17
|
5.31e-01
|
8.74e-01
|
0.15500
|
9.93e-02
|
-0.119000
|
4.79e-01
|
3.96e-01
|
|
REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION
|
55
|
1.40e-01
|
5.50e-01
|
0.15400
|
-1.53e-01
|
0.017900
|
5.00e-02
|
8.19e-01
|
|
REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES
|
12
|
6.63e-01
|
9.09e-01
|
0.15400
|
-1.23e-01
|
-0.092100
|
4.61e-01
|
5.81e-01
|
|
REACTOME NUCLEAR SIGNALING BY ERBB4
|
21
|
4.65e-01
|
8.36e-01
|
0.15300
|
9.27e-02
|
-0.122000
|
4.62e-01
|
3.32e-01
|
|
REACTOME SIGNALING BY NOTCH
|
71
|
7.79e-02
|
4.22e-01
|
0.15300
|
-7.32e-02
|
0.134000
|
2.87e-01
|
5.06e-02
|
|
REACTOME RNA POL III TRANSCRIPTION TERMINATION
|
18
|
5.25e-01
|
8.71e-01
|
0.15200
|
9.38e-02
|
-0.120000
|
4.91e-01
|
3.80e-01
|
|
REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
|
18
|
5.39e-01
|
8.80e-01
|
0.15100
|
-1.64e-02
|
0.150000
|
9.04e-01
|
2.71e-01
|
|
REACTOME INTERFERON GAMMA SIGNALING
|
23
|
4.70e-01
|
8.41e-01
|
0.15000
|
7.18e-02
|
0.132000
|
5.51e-01
|
2.73e-01
|
|
REACTOME SIGNALING BY FGFR1 FUSION MUTANTS
|
16
|
5.79e-01
|
8.98e-01
|
0.14900
|
-1.38e-01
|
0.057100
|
3.41e-01
|
6.93e-01
|
|
REACTOME DESTABILIZATION OF MRNA BY BRF1
|
16
|
5.87e-01
|
8.98e-01
|
0.14800
|
2.85e-02
|
-0.145000
|
8.44e-01
|
3.15e-01
|
|
REACTOME REGULATION OF INSULIN SECRETION
|
36
|
3.21e-01
|
7.90e-01
|
0.14800
|
-8.84e-02
|
-0.118000
|
3.59e-01
|
2.20e-01
|
|
REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY
|
27
|
4.34e-01
|
8.19e-01
|
0.14500
|
1.39e-01
|
0.040500
|
2.10e-01
|
7.16e-01
|
|
REACTOME CA DEPENDENT EVENTS
|
13
|
6.69e-01
|
9.09e-01
|
0.14500
|
1.38e-01
|
0.045900
|
3.90e-01
|
7.75e-01
|
|
REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION
|
20
|
5.32e-01
|
8.74e-01
|
0.14500
|
-1.15e-02
|
0.144000
|
9.29e-01
|
2.64e-01
|
|
REACTOME GRB2 EVENTS IN ERBB2 SIGNALING
|
14
|
6.55e-01
|
9.09e-01
|
0.14400
|
1.24e-01
|
0.072700
|
4.20e-01
|
6.38e-01
|
|
REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION
|
17
|
5.85e-01
|
8.98e-01
|
0.14400
|
1.41e-01
|
-0.028100
|
3.13e-01
|
8.41e-01
|
|
REACTOME METABOLISM OF MRNA
|
176
|
5.24e-03
|
7.02e-02
|
0.14300
|
-2.46e-02
|
-0.141000
|
5.76e-01
|
1.33e-03
|
|
REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION
|
21
|
5.24e-01
|
8.71e-01
|
0.14300
|
-1.42e-01
|
0.017700
|
2.62e-01
|
8.88e-01
|
|
REACTOME GENERIC TRANSCRIPTION PATHWAY
|
135
|
1.80e-02
|
1.68e-01
|
0.14200
|
5.67e-03
|
0.142000
|
9.10e-01
|
4.58e-03
|
|
REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2
|
46
|
2.48e-01
|
7.05e-01
|
0.14200
|
-1.41e-01
|
0.016300
|
9.86e-02
|
8.49e-01
|
|
REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT
|
22
|
5.08e-01
|
8.66e-01
|
0.14100
|
1.17e-01
|
-0.078300
|
3.41e-01
|
5.25e-01
|
|
REACTOME CTNNB1 PHOSPHORYLATION CASCADE
|
14
|
6.54e-01
|
9.09e-01
|
0.14100
|
-1.33e-01
|
0.044800
|
3.88e-01
|
7.72e-01
|
|
REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS
|
17
|
6.15e-01
|
9.02e-01
|
0.14100
|
-1.15e-01
|
-0.080500
|
4.11e-01
|
5.66e-01
|
|
REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE
|
56
|
1.97e-01
|
6.14e-01
|
0.13800
|
-1.36e-01
|
0.028500
|
7.99e-02
|
7.13e-01
|
|
REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA
|
19
|
5.95e-01
|
8.98e-01
|
0.13700
|
1.25e-01
|
0.056600
|
3.47e-01
|
6.70e-01
|
|
REACTOME G ALPHA Q SIGNALLING EVENTS
|
39
|
3.48e-01
|
7.95e-01
|
0.13600
|
-6.24e-02
|
-0.121000
|
5.00e-01
|
1.90e-01
|
|
REACTOME SEMA4D IN SEMAPHORIN SIGNALING
|
21
|
5.61e-01
|
8.95e-01
|
0.13500
|
-3.73e-03
|
0.135000
|
9.76e-01
|
2.83e-01
|
|
REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS
|
16
|
6.41e-01
|
9.09e-01
|
0.13500
|
2.62e-02
|
-0.133000
|
8.56e-01
|
3.58e-01
|
|
REACTOME RNA POL III CHAIN ELONGATION
|
16
|
6.39e-01
|
9.09e-01
|
0.13500
|
1.14e-01
|
-0.071800
|
4.31e-01
|
6.19e-01
|
|
REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS
|
16
|
6.52e-01
|
9.09e-01
|
0.13300
|
-1.63e-02
|
0.132000
|
9.10e-01
|
3.61e-01
|
|
REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS
|
17
|
6.32e-01
|
9.09e-01
|
0.13300
|
4.76e-02
|
-0.124000
|
7.34e-01
|
3.77e-01
|
|
REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS
|
17
|
6.32e-01
|
9.09e-01
|
0.13300
|
4.76e-02
|
-0.124000
|
7.34e-01
|
3.77e-01
|
|
REACTOME MRNA SPLICING MINOR PATHWAY
|
38
|
3.56e-01
|
7.95e-01
|
0.13300
|
1.05e-01
|
-0.081200
|
2.64e-01
|
3.87e-01
|
|
REACTOME SIGNALING BY NOTCH1
|
47
|
2.87e-01
|
7.47e-01
|
0.13300
|
-2.24e-02
|
0.131000
|
7.91e-01
|
1.22e-01
|
|
REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE
|
50
|
2.72e-01
|
7.34e-01
|
0.13200
|
-1.32e-01
|
-0.008610
|
1.07e-01
|
9.16e-01
|
|
REACTOME METABOLISM OF PROTEINS
|
301
|
4.95e-04
|
9.79e-03
|
0.13200
|
-9.73e-03
|
-0.132000
|
7.74e-01
|
9.67e-05
|
|
REACTOME NUCLEOTIDE EXCISION REPAIR
|
37
|
3.74e-01
|
7.95e-01
|
0.13200
|
1.27e-01
|
-0.036100
|
1.82e-01
|
7.04e-01
|
|
REACTOME ASPARAGINE N LINKED GLYCOSYLATION
|
63
|
1.94e-01
|
6.14e-01
|
0.13200
|
-7.34e-03
|
0.132000
|
9.20e-01
|
7.11e-02
|
|
REACTOME INTERFERON SIGNALING
|
74
|
1.52e-01
|
5.55e-01
|
0.13200
|
2.44e-02
|
0.129000
|
7.18e-01
|
5.49e-02
|
|
REACTOME IL RECEPTOR SHC SIGNALING
|
15
|
6.71e-01
|
9.09e-01
|
0.13100
|
1.18e-01
|
-0.057400
|
4.28e-01
|
7.00e-01
|
|
REACTOME SIGNALING BY HIPPO
|
15
|
6.83e-01
|
9.14e-01
|
0.13100
|
3.24e-02
|
0.127000
|
8.28e-01
|
3.94e-01
|
|
REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING
|
36
|
3.90e-01
|
7.95e-01
|
0.13100
|
4.35e-02
|
-0.123000
|
6.52e-01
|
2.01e-01
|
|
REACTOME G2 M CHECKPOINTS
|
17
|
6.53e-01
|
9.09e-01
|
0.13000
|
1.73e-02
|
0.129000
|
9.02e-01
|
3.58e-01
|
|
REACTOME MEIOSIS
|
24
|
5.36e-01
|
8.77e-01
|
0.13000
|
-7.56e-02
|
0.105000
|
5.22e-01
|
3.72e-01
|
|
REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC
|
14
|
6.97e-01
|
9.20e-01
|
0.12900
|
1.01e-01
|
-0.079800
|
5.12e-01
|
6.06e-01
|
|
REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING
|
17
|
6.64e-01
|
9.09e-01
|
0.12900
|
-1.08e-01
|
-0.070300
|
4.41e-01
|
6.16e-01
|
|
REACTOME DIABETES PATHWAYS
|
90
|
1.06e-01
|
4.84e-01
|
0.12800
|
-3.25e-02
|
0.124000
|
5.95e-01
|
4.21e-02
|
|
REACTOME SIGNALING BY FGFR1 MUTANTS
|
19
|
6.19e-01
|
9.02e-01
|
0.12800
|
-1.20e-01
|
0.046700
|
3.67e-01
|
7.25e-01
|
|
REACTOME DEADENYLATION DEPENDENT MRNA DECAY
|
37
|
3.91e-01
|
7.95e-01
|
0.12800
|
1.05e-01
|
-0.072900
|
2.68e-01
|
4.43e-01
|
|
REACTOME PLC BETA MEDIATED EVENTS
|
19
|
6.36e-01
|
9.09e-01
|
0.12800
|
1.11e-01
|
0.063700
|
4.03e-01
|
6.31e-01
|
|
REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER
|
31
|
4.63e-01
|
8.36e-01
|
0.12800
|
-3.15e-02
|
0.124000
|
7.61e-01
|
2.33e-01
|
|
REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE
|
18
|
6.51e-01
|
9.09e-01
|
0.12800
|
1.21e-01
|
0.040200
|
3.74e-01
|
7.68e-01
|
|
REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A
|
17
|
6.62e-01
|
9.09e-01
|
0.12700
|
1.26e-01
|
-0.009130
|
3.67e-01
|
9.48e-01
|
|
REACTOME SHC1 EVENTS IN ERBB4 SIGNALING
|
13
|
7.42e-01
|
9.38e-01
|
0.12600
|
7.58e-02
|
0.101000
|
6.36e-01
|
5.30e-01
|
|
REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS
|
18
|
6.43e-01
|
9.09e-01
|
0.12600
|
-1.04e-01
|
0.070200
|
4.43e-01
|
6.06e-01
|
|
REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
|
13
|
7.41e-01
|
9.38e-01
|
0.12400
|
8.04e-03
|
0.124000
|
9.60e-01
|
4.38e-01
|
|
REACTOME MTORC1 MEDIATED SIGNALLING
|
11
|
7.70e-01
|
9.44e-01
|
0.12400
|
8.18e-02
|
-0.092800
|
6.39e-01
|
5.94e-01
|
|
REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE
|
10
|
7.91e-01
|
9.44e-01
|
0.12300
|
1.09e-01
|
-0.058600
|
5.52e-01
|
7.48e-01
|
|
REACTOME DNA REPAIR
|
65
|
2.36e-01
|
6.88e-01
|
0.12300
|
1.17e-01
|
0.039200
|
1.04e-01
|
5.85e-01
|
|
REACTOME SIGNALING BY SCF KIT
|
56
|
2.91e-01
|
7.47e-01
|
0.12300
|
-1.14e-01
|
-0.046000
|
1.40e-01
|
5.53e-01
|
|
REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE
|
23
|
6.08e-01
|
9.02e-01
|
0.12200
|
-3.92e-02
|
-0.115000
|
7.45e-01
|
3.40e-01
|
|
REACTOME PHOSPHORYLATION OF THE APC C
|
14
|
7.33e-01
|
9.38e-01
|
0.12100
|
1.20e-01
|
-0.018500
|
4.38e-01
|
9.04e-01
|
|
REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS
|
18
|
6.79e-01
|
9.11e-01
|
0.12100
|
-1.19e-01
|
-0.019900
|
3.83e-01
|
8.84e-01
|
|
REACTOME ERK MAPK TARGETS
|
18
|
6.69e-01
|
9.09e-01
|
0.12000
|
-1.08e-01
|
0.053300
|
4.28e-01
|
6.96e-01
|
|
REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX
|
35
|
4.60e-01
|
8.36e-01
|
0.12000
|
8.28e-02
|
-0.086500
|
3.97e-01
|
3.76e-01
|
|
REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES
|
49
|
3.50e-01
|
7.95e-01
|
0.11900
|
-1.41e-02
|
0.118000
|
8.65e-01
|
1.52e-01
|
|
REACTOME SEMAPHORIN INTERACTIONS
|
41
|
4.08e-01
|
8.04e-01
|
0.11900
|
-7.15e-02
|
0.095100
|
4.29e-01
|
2.93e-01
|
|
REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS
|
26
|
5.72e-01
|
8.98e-01
|
0.11900
|
-3.12e-02
|
0.115000
|
7.83e-01
|
3.13e-01
|
|
REACTOME METABOLISM OF NON CODING RNA
|
39
|
4.30e-01
|
8.15e-01
|
0.11800
|
-1.02e-01
|
0.060500
|
2.71e-01
|
5.14e-01
|
|
REACTOME GROWTH HORMONE RECEPTOR SIGNALING
|
15
|
7.35e-01
|
9.38e-01
|
0.11800
|
-1.08e-01
|
-0.048400
|
4.69e-01
|
7.45e-01
|
|
REACTOME MAP KINASE ACTIVATION IN TLR CASCADE
|
41
|
4.23e-01
|
8.12e-01
|
0.11800
|
-1.18e-01
|
0.006500
|
1.91e-01
|
9.43e-01
|
|
REACTOME SIGNALING BY BMP
|
17
|
7.14e-01
|
9.29e-01
|
0.11700
|
8.75e-02
|
0.077800
|
5.32e-01
|
5.79e-01
|
|
REACTOME ELONGATION ARREST AND RECOVERY
|
24
|
6.04e-01
|
9.02e-01
|
0.11700
|
8.56e-02
|
-0.079000
|
4.68e-01
|
5.03e-01
|
|
REACTOME SHC1 EVENTS IN EGFR SIGNALING
|
14
|
7.60e-01
|
9.42e-01
|
0.11600
|
7.89e-02
|
0.085600
|
6.10e-01
|
5.79e-01
|
|
REACTOME IL 2 SIGNALING
|
25
|
5.96e-01
|
8.98e-01
|
0.11600
|
8.32e-02
|
-0.080100
|
4.72e-01
|
4.88e-01
|
|
REACTOME METABOLISM OF NUCLEOTIDES
|
46
|
3.92e-01
|
7.95e-01
|
0.11500
|
5.17e-02
|
-0.103000
|
5.44e-01
|
2.28e-01
|
|
REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1
|
14
|
7.54e-01
|
9.42e-01
|
0.11400
|
-7.08e-02
|
0.089300
|
6.47e-01
|
5.63e-01
|
|
REACTOME METABOLISM OF RNA
|
212
|
2.00e-02
|
1.72e-01
|
0.11300
|
-3.79e-02
|
-0.107000
|
3.45e-01
|
7.70e-03
|
|
REACTOME IRON UPTAKE AND TRANSPORT
|
23
|
6.61e-01
|
9.09e-01
|
0.11100
|
-9.76e-02
|
-0.053500
|
4.18e-01
|
6.57e-01
|
|
REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS
|
36
|
5.28e-01
|
8.73e-01
|
0.11100
|
-9.91e-02
|
-0.049000
|
3.04e-01
|
6.11e-01
|
|
REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0
|
45
|
4.42e-01
|
8.25e-01
|
0.11000
|
1.12e-02
|
-0.109000
|
8.97e-01
|
2.06e-01
|
|
REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT
|
27
|
6.09e-01
|
9.02e-01
|
0.10900
|
-7.08e-02
|
0.082700
|
5.25e-01
|
4.58e-01
|
|
REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY
|
18
|
7.35e-01
|
9.38e-01
|
0.10800
|
4.43e-02
|
0.098800
|
7.45e-01
|
4.68e-01
|
|
REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER
|
24
|
6.65e-01
|
9.09e-01
|
0.10800
|
-4.85e-02
|
-0.096600
|
6.81e-01
|
4.13e-01
|
|
REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK
|
57
|
3.86e-01
|
7.95e-01
|
0.10700
|
-5.84e-02
|
-0.090200
|
4.47e-01
|
2.39e-01
|
|
REACTOME ANTIGEN PROCESSING CROSS PRESENTATION
|
56
|
3.99e-01
|
7.96e-01
|
0.10600
|
-1.04e-01
|
-0.019500
|
1.80e-01
|
8.01e-01
|
|
REACTOME INSULIN RECEPTOR RECYCLING
|
15
|
7.89e-01
|
9.44e-01
|
0.10400
|
-9.97e-02
|
-0.028300
|
5.04e-01
|
8.50e-01
|
|
REACTOME DARPP 32 EVENTS
|
17
|
7.69e-01
|
9.44e-01
|
0.10300
|
3.30e-02
|
0.097100
|
8.14e-01
|
4.89e-01
|
|
REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX
|
50
|
4.57e-01
|
8.36e-01
|
0.10100
|
-4.62e-02
|
0.089800
|
5.73e-01
|
2.73e-01
|
|
REACTOME SOS MEDIATED SIGNALLING
|
13
|
8.19e-01
|
9.44e-01
|
0.09970
|
-8.29e-02
|
0.055400
|
6.05e-01
|
7.30e-01
|
|
REACTOME TRANSCRIPTION COUPLED NER TC NER
|
34
|
5.96e-01
|
8.98e-01
|
0.09970
|
9.26e-02
|
-0.037000
|
3.51e-01
|
7.09e-01
|
|
REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN
|
18
|
7.73e-01
|
9.44e-01
|
0.09900
|
-3.71e-02
|
-0.091800
|
7.85e-01
|
5.01e-01
|
|
REACTOME UNFOLDED PROTEIN RESPONSE
|
64
|
4.05e-01
|
8.04e-01
|
0.09810
|
2.20e-02
|
0.095600
|
7.61e-01
|
1.87e-01
|
|
REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION
|
98
|
2.40e-01
|
6.92e-01
|
0.09800
|
-3.04e-02
|
0.093100
|
6.04e-01
|
1.12e-01
|
|
REACTOME SIGNALING BY RHO GTPASES
|
61
|
4.12e-01
|
8.04e-01
|
0.09790
|
-9.44e-02
|
0.025700
|
2.03e-01
|
7.29e-01
|
|
REACTOME TRIGLYCERIDE BIOSYNTHESIS
|
20
|
7.53e-01
|
9.42e-01
|
0.09700
|
-9.61e-02
|
0.012800
|
4.57e-01
|
9.21e-01
|
|
REACTOME NRAGE SIGNALS DEATH THROUGH JNK
|
26
|
6.92e-01
|
9.18e-01
|
0.09680
|
-1.47e-02
|
0.095600
|
8.97e-01
|
3.99e-01
|
|
REACTOME RNA POL III TRANSCRIPTION
|
30
|
6.66e-01
|
9.09e-01
|
0.09620
|
-9.18e-02
|
-0.028700
|
3.85e-01
|
7.86e-01
|
|
REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL
|
11
|
8.65e-01
|
9.65e-01
|
0.09490
|
8.74e-02
|
0.037000
|
6.16e-01
|
8.32e-01
|
|
REACTOME L1CAM INTERACTIONS
|
51
|
5.19e-01
|
8.69e-01
|
0.09270
|
-1.62e-03
|
0.092700
|
9.84e-01
|
2.53e-01
|
|
REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE
|
11
|
8.72e-01
|
9.65e-01
|
0.09270
|
-4.37e-02
|
-0.081700
|
8.02e-01
|
6.39e-01
|
|
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G
|
42
|
5.76e-01
|
8.98e-01
|
0.09220
|
5.62e-02
|
-0.073000
|
5.29e-01
|
4.14e-01
|
|
REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS
|
23
|
7.48e-01
|
9.40e-01
|
0.09120
|
8.94e-02
|
-0.017700
|
4.58e-01
|
8.83e-01
|
|
REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
|
11
|
8.71e-01
|
9.65e-01
|
0.09010
|
-5.10e-02
|
0.074300
|
7.70e-01
|
6.70e-01
|
|
REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B
|
16
|
8.24e-01
|
9.44e-01
|
0.08970
|
8.95e-02
|
-0.005770
|
5.36e-01
|
9.68e-01
|
|
REACTOME ACTIVATION OF GENES BY ATF4
|
18
|
8.05e-01
|
9.44e-01
|
0.08920
|
1.36e-02
|
-0.088100
|
9.20e-01
|
5.18e-01
|
|
REACTOME LATE PHASE OF HIV LIFE CYCLE
|
83
|
3.88e-01
|
7.95e-01
|
0.08860
|
3.19e-02
|
0.082700
|
6.16e-01
|
1.94e-01
|
|
REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS
|
72
|
4.28e-01
|
8.15e-01
|
0.08800
|
2.74e-02
|
-0.083600
|
6.88e-01
|
2.21e-01
|
|
REACTOME HIV LIFE CYCLE
|
91
|
3.63e-01
|
7.95e-01
|
0.08790
|
4.66e-02
|
0.074600
|
4.44e-01
|
2.20e-01
|
|
REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS
|
56
|
5.13e-01
|
8.66e-01
|
0.08790
|
7.25e-02
|
-0.049700
|
3.49e-01
|
5.21e-01
|
|
REACTOME HEMOSTASIS
|
210
|
9.65e-02
|
4.72e-01
|
0.08710
|
-8.71e-02
|
0.000897
|
3.07e-02
|
9.82e-01
|
|
REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX
|
26
|
7.40e-01
|
9.38e-01
|
0.08660
|
5.05e-02
|
-0.070300
|
6.56e-01
|
5.35e-01
|
|
REACTOME REGULATION OF MITOTIC CELL CYCLE
|
60
|
5.00e-01
|
8.62e-01
|
0.08650
|
5.84e-02
|
-0.063800
|
4.35e-01
|
3.94e-01
|
|
REACTOME SHC MEDIATED SIGNALLING
|
13
|
8.64e-01
|
9.65e-01
|
0.08540
|
-3.94e-02
|
0.075800
|
8.06e-01
|
6.36e-01
|
|
REACTOME NOD1 2 SIGNALING PATHWAY
|
17
|
8.26e-01
|
9.44e-01
|
0.08520
|
5.84e-02
|
-0.062100
|
6.77e-01
|
6.58e-01
|
|
REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING
|
19
|
8.23e-01
|
9.44e-01
|
0.08320
|
-8.16e-02
|
-0.016200
|
5.38e-01
|
9.03e-01
|
|
REACTOME PYRIMIDINE METABOLISM
|
10
|
9.05e-01
|
9.69e-01
|
0.08250
|
-7.93e-02
|
-0.022800
|
6.64e-01
|
9.01e-01
|
|
REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE
|
100
|
3.62e-01
|
7.95e-01
|
0.08170
|
-3.21e-02
|
0.075100
|
5.80e-01
|
1.96e-01
|
|
REACTOME SIGNALLING BY NGF
|
149
|
2.26e-01
|
6.68e-01
|
0.08140
|
-2.36e-02
|
0.078000
|
6.21e-01
|
1.02e-01
|
|
REACTOME SHC RELATED EVENTS
|
14
|
8.69e-01
|
9.65e-01
|
0.08110
|
-1.55e-02
|
0.079600
|
9.20e-01
|
6.06e-01
|
|
REACTOME INSULIN RECEPTOR SIGNALLING CASCADE
|
58
|
5.63e-01
|
8.95e-01
|
0.08040
|
-3.75e-02
|
0.071100
|
6.22e-01
|
3.50e-01
|
|
REACTOME IL1 SIGNALING
|
24
|
8.02e-01
|
9.44e-01
|
0.07990
|
5.52e-02
|
0.057700
|
6.40e-01
|
6.25e-01
|
|
REACTOME INTERFERON ALPHA BETA SIGNALING
|
13
|
8.89e-01
|
9.69e-01
|
0.07920
|
4.96e-02
|
0.061700
|
7.57e-01
|
7.00e-01
|
|
REACTOME ACTIVATION OF NF KAPPAB IN B CELLS
|
53
|
6.23e-01
|
9.06e-01
|
0.07860
|
-4.26e-02
|
-0.066000
|
5.92e-01
|
4.07e-01
|
|
REACTOME CALNEXIN CALRETICULIN CYCLE
|
11
|
9.04e-01
|
9.69e-01
|
0.07850
|
1.03e-02
|
0.077800
|
9.53e-01
|
6.55e-01
|
|
REACTOME CHROMOSOME MAINTENANCE
|
33
|
7.34e-01
|
9.38e-01
|
0.07840
|
7.49e-02
|
-0.023300
|
4.57e-01
|
8.17e-01
|
|
REACTOME INSULIN SYNTHESIS AND PROCESSING
|
13
|
8.87e-01
|
9.69e-01
|
0.07830
|
-7.83e-02
|
-0.000883
|
6.25e-01
|
9.96e-01
|
|
REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1
|
56
|
5.91e-01
|
8.98e-01
|
0.07800
|
4.85e-02
|
-0.061100
|
5.31e-01
|
4.30e-01
|
|
REACTOME SIGNALING BY ERBB4
|
66
|
5.46e-01
|
8.84e-01
|
0.07720
|
6.30e-02
|
-0.044600
|
3.77e-01
|
5.32e-01
|
|
REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION
|
23
|
8.17e-01
|
9.44e-01
|
0.07650
|
-1.60e-03
|
0.076500
|
9.89e-01
|
5.26e-01
|
|
REACTOME G0 AND EARLY G1
|
11
|
9.12e-01
|
9.69e-01
|
0.07620
|
5.66e-02
|
0.051100
|
7.45e-01
|
7.69e-01
|
|
REACTOME RNA POL II PRE TRANSCRIPTION EVENTS
|
48
|
6.63e-01
|
9.09e-01
|
0.07470
|
3.27e-02
|
-0.067200
|
6.96e-01
|
4.21e-01
|
|
REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK
|
17
|
8.65e-01
|
9.65e-01
|
0.07460
|
-3.24e-02
|
0.067100
|
8.17e-01
|
6.32e-01
|
|
REACTOME SIGNALING BY INSULIN RECEPTOR
|
72
|
5.42e-01
|
8.81e-01
|
0.07430
|
-5.53e-02
|
0.049600
|
4.19e-01
|
4.68e-01
|
|
REACTOME SIGNALING BY EGFR IN CANCER
|
82
|
5.12e-01
|
8.66e-01
|
0.07380
|
-5.47e-03
|
0.073600
|
9.32e-01
|
2.50e-01
|
|
REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1
|
42
|
7.06e-01
|
9.22e-01
|
0.07330
|
5.31e-02
|
-0.050500
|
5.52e-01
|
5.72e-01
|
|
REACTOME SIGNALING BY ERBB2
|
67
|
5.95e-01
|
8.98e-01
|
0.07320
|
6.48e-02
|
0.034100
|
3.60e-01
|
6.30e-01
|
|
REACTOME PI3K CASCADE
|
44
|
6.99e-01
|
9.20e-01
|
0.07310
|
-1.92e-02
|
0.070600
|
8.26e-01
|
4.19e-01
|
|
REACTOME NEURONAL SYSTEM
|
86
|
4.97e-01
|
8.61e-01
|
0.07280
|
3.80e-02
|
-0.062200
|
5.44e-01
|
3.20e-01
|
|
REACTOME PIP3 ACTIVATES AKT SIGNALING
|
25
|
8.15e-01
|
9.44e-01
|
0.07260
|
4.37e-02
|
-0.058000
|
7.05e-01
|
6.16e-01
|
|
REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS
|
23
|
8.39e-01
|
9.50e-01
|
0.07240
|
-3.36e-02
|
-0.064100
|
7.80e-01
|
5.95e-01
|
|
REACTOME PERK REGULATED GENE EXPRESSION
|
21
|
8.56e-01
|
9.65e-01
|
0.07150
|
-3.92e-02
|
-0.059900
|
7.56e-01
|
6.35e-01
|
|
REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS
|
24
|
8.30e-01
|
9.44e-01
|
0.07120
|
2.29e-02
|
-0.067400
|
8.46e-01
|
5.68e-01
|
|
REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION
|
162
|
2.94e-01
|
7.51e-01
|
0.07080
|
6.61e-02
|
-0.025400
|
1.49e-01
|
5.80e-01
|
|
REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE
|
36
|
7.70e-01
|
9.44e-01
|
0.07050
|
2.61e-02
|
0.065500
|
7.87e-01
|
4.97e-01
|
|
REACTOME OPIOID SIGNALLING
|
38
|
7.56e-01
|
9.42e-01
|
0.06990
|
7.70e-03
|
-0.069400
|
9.35e-01
|
4.60e-01
|
|
REACTOME PI 3K CASCADE
|
33
|
7.93e-01
|
9.44e-01
|
0.06980
|
-4.72e-02
|
-0.051400
|
6.39e-01
|
6.10e-01
|
|
REACTOME TRANS GOLGI NETWORK VESICLE BUDDING
|
50
|
6.97e-01
|
9.20e-01
|
0.06980
|
8.13e-03
|
0.069300
|
9.21e-01
|
3.97e-01
|
|
REACTOME TRAF6 MEDIATED IRF7 ACTIVATION
|
12
|
9.14e-01
|
9.69e-01
|
0.06950
|
-4.85e-02
|
0.049800
|
7.71e-01
|
7.65e-01
|
|
REACTOME PI METABOLISM
|
38
|
7.59e-01
|
9.42e-01
|
0.06920
|
6.74e-02
|
-0.015500
|
4.73e-01
|
8.69e-01
|
|
REACTOME PKB MEDIATED EVENTS
|
27
|
8.32e-01
|
9.44e-01
|
0.06860
|
4.15e-02
|
0.054600
|
7.09e-01
|
6.24e-01
|
|
REACTOME VITAMIN B5 PANTOTHENATE METABOLISM
|
10
|
9.33e-01
|
9.72e-01
|
0.06840
|
-1.43e-02
|
-0.066900
|
9.38e-01
|
7.14e-01
|
|
REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC
|
43
|
7.37e-01
|
9.38e-01
|
0.06770
|
4.39e-02
|
-0.051600
|
6.19e-01
|
5.59e-01
|
|
REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT
|
42
|
7.45e-01
|
9.39e-01
|
0.06730
|
4.25e-02
|
-0.052100
|
6.34e-01
|
5.59e-01
|
|
REACTOME DNA STRAND ELONGATION
|
12
|
9.24e-01
|
9.69e-01
|
0.06690
|
-1.37e-02
|
-0.065500
|
9.35e-01
|
6.95e-01
|
|
REACTOME PI3K EVENTS IN ERBB4 SIGNALING
|
28
|
8.29e-01
|
9.44e-01
|
0.06580
|
4.98e-02
|
-0.043000
|
6.49e-01
|
6.94e-01
|
|
REACTOME CELL CYCLE CHECKPOINTS
|
77
|
6.18e-01
|
9.02e-01
|
0.06540
|
6.25e-02
|
0.019200
|
3.44e-01
|
7.72e-01
|
|
REACTOME RECYCLING PATHWAY OF L1
|
19
|
8.88e-01
|
9.69e-01
|
0.06400
|
-1.94e-02
|
0.061000
|
8.84e-01
|
6.46e-01
|
|
REACTOME FRS2 MEDIATED CASCADE
|
15
|
9.14e-01
|
9.69e-01
|
0.06340
|
-6.29e-02
|
-0.007960
|
6.73e-01
|
9.57e-01
|
|
REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER
|
21
|
8.85e-01
|
9.69e-01
|
0.06300
|
2.23e-02
|
0.058900
|
8.60e-01
|
6.41e-01
|
|
REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C
|
53
|
7.25e-01
|
9.37e-01
|
0.06270
|
4.03e-02
|
-0.048100
|
6.12e-01
|
5.46e-01
|
|
REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM
|
138
|
4.60e-01
|
8.36e-01
|
0.06110
|
-1.67e-02
|
0.058800
|
7.36e-01
|
2.35e-01
|
|
REACTOME PROTEIN FOLDING
|
40
|
8.00e-01
|
9.44e-01
|
0.06100
|
6.08e-02
|
-0.004440
|
5.06e-01
|
9.61e-01
|
|
REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS
|
12
|
9.36e-01
|
9.72e-01
|
0.06060
|
-6.06e-02
|
0.000801
|
7.16e-01
|
9.96e-01
|
|
REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6
|
40
|
7.98e-01
|
9.44e-01
|
0.06050
|
3.16e-02
|
-0.051600
|
7.30e-01
|
5.73e-01
|
|
REACTOME CELL CYCLE
|
208
|
3.48e-01
|
7.95e-01
|
0.05960
|
5.33e-02
|
0.026600
|
1.88e-01
|
5.11e-01
|
|
REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES
|
62
|
7.14e-01
|
9.29e-01
|
0.05960
|
2.23e-02
|
-0.055300
|
7.62e-01
|
4.52e-01
|
|
REACTOME GPCR DOWNSTREAM SIGNALING
|
102
|
5.84e-01
|
8.98e-01
|
0.05950
|
-5.95e-02
|
0.001080
|
3.00e-01
|
9.85e-01
|
|
REACTOME G1 S TRANSITION
|
67
|
7.19e-01
|
9.31e-01
|
0.05860
|
-3.96e-02
|
-0.043100
|
5.76e-01
|
5.42e-01
|
|
REACTOME MRNA SPLICING
|
99
|
5.94e-01
|
8.98e-01
|
0.05850
|
3.99e-02
|
-0.042800
|
4.94e-01
|
4.63e-01
|
|
REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE
|
46
|
7.91e-01
|
9.44e-01
|
0.05820
|
5.78e-02
|
-0.007020
|
4.98e-01
|
9.34e-01
|
|
REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR
|
81
|
6.77e-01
|
9.11e-01
|
0.05710
|
-6.43e-03
|
-0.056700
|
9.20e-01
|
3.79e-01
|
|
REACTOME SIGNALLING TO RAS
|
20
|
9.07e-01
|
9.69e-01
|
0.05610
|
4.34e-02
|
-0.035600
|
7.37e-01
|
7.83e-01
|
|
REACTOME SIGNALING BY GPCR
|
143
|
5.19e-01
|
8.69e-01
|
0.05530
|
-5.43e-02
|
0.010400
|
2.64e-01
|
8.32e-01
|
|
REACTOME REGULATION OF APOPTOSIS
|
48
|
8.03e-01
|
9.44e-01
|
0.05500
|
5.47e-02
|
-0.006180
|
5.13e-01
|
9.41e-01
|
|
REACTOME PPARA ACTIVATES GENE EXPRESSION
|
80
|
6.90e-01
|
9.18e-01
|
0.05490
|
-4.39e-02
|
0.033000
|
4.98e-01
|
6.10e-01
|
|
REACTOME CELL CYCLE MITOTIC
|
183
|
4.54e-01
|
8.36e-01
|
0.05480
|
5.14e-02
|
0.018900
|
2.33e-01
|
6.61e-01
|
|
REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS
|
44
|
8.20e-01
|
9.44e-01
|
0.05460
|
-8.60e-03
|
0.053900
|
9.21e-01
|
5.37e-01
|
|
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR
|
58
|
7.78e-01
|
9.44e-01
|
0.05460
|
5.11e-02
|
0.019200
|
5.02e-01
|
8.01e-01
|
|
REACTOME IMMUNE SYSTEM
|
504
|
1.19e-01
|
5.00e-01
|
0.05410
|
-1.34e-02
|
0.052400
|
6.12e-01
|
4.75e-02
|
|
REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX
|
47
|
8.21e-01
|
9.44e-01
|
0.05310
|
-4.11e-03
|
-0.053000
|
9.61e-01
|
5.31e-01
|
|
REACTOME INTEGRATION OF ENERGY METABOLISM
|
58
|
7.89e-01
|
9.44e-01
|
0.05310
|
-4.89e-02
|
-0.020600
|
5.20e-01
|
7.86e-01
|
|
REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL
|
49
|
8.19e-01
|
9.44e-01
|
0.05230
|
-4.32e-03
|
-0.052200
|
9.58e-01
|
5.28e-01
|
|
REACTOME SIGNALING BY THE B CELL RECEPTOR BCR
|
96
|
6.90e-01
|
9.18e-01
|
0.05190
|
-3.03e-02
|
-0.042100
|
6.09e-01
|
4.77e-01
|
|
REACTOME ER PHAGOSOME PATHWAY
|
48
|
8.32e-01
|
9.44e-01
|
0.05150
|
-2.43e-02
|
-0.045300
|
7.71e-01
|
5.87e-01
|
|
REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING
|
49
|
8.30e-01
|
9.44e-01
|
0.05120
|
2.54e-02
|
0.044400
|
7.59e-01
|
5.91e-01
|
|
REACTOME M G1 TRANSITION
|
50
|
8.23e-01
|
9.44e-01
|
0.05080
|
5.99e-03
|
-0.050400
|
9.42e-01
|
5.38e-01
|
|
REACTOME HIV INFECTION
|
154
|
5.77e-01
|
8.98e-01
|
0.05000
|
3.95e-02
|
0.030800
|
4.00e-01
|
5.12e-01
|
|
REACTOME BASE EXCISION REPAIR
|
11
|
9.61e-01
|
9.86e-01
|
0.04960
|
2.70e-02
|
0.041600
|
8.77e-01
|
8.11e-01
|
|
REACTOME G ALPHA1213 SIGNALLING EVENTS
|
42
|
8.62e-01
|
9.65e-01
|
0.04890
|
-4.85e-02
|
-0.005790
|
5.87e-01
|
9.48e-01
|
|
REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION
|
187
|
5.10e-01
|
8.66e-01
|
0.04870
|
4.13e-02
|
-0.025800
|
3.33e-01
|
5.45e-01
|
|
REACTOME MRNA 3 END PROCESSING
|
31
|
9.05e-01
|
9.69e-01
|
0.04720
|
3.26e-02
|
0.034200
|
7.54e-01
|
7.42e-01
|
|
REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM
|
125
|
6.76e-01
|
9.11e-01
|
0.04550
|
1.34e-02
|
-0.043500
|
7.96e-01
|
4.03e-01
|
|
REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
|
42
|
8.77e-01
|
9.68e-01
|
0.04540
|
1.18e-02
|
-0.043800
|
8.95e-01
|
6.24e-01
|
|
REACTOME PI3K AKT ACTIVATION
|
31
|
9.15e-01
|
9.69e-01
|
0.04460
|
-2.57e-02
|
-0.036400
|
8.05e-01
|
7.26e-01
|
|
REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT
|
92
|
7.77e-01
|
9.44e-01
|
0.04380
|
3.51e-02
|
0.026200
|
5.62e-01
|
6.65e-01
|
|
REACTOME MITOTIC G1 G1 S PHASES
|
82
|
7.98e-01
|
9.44e-01
|
0.04320
|
-4.27e-02
|
-0.006450
|
5.05e-01
|
9.20e-01
|
|
REACTOME PI3K EVENTS IN ERBB2 SIGNALING
|
32
|
9.26e-01
|
9.69e-01
|
0.03940
|
3.54e-02
|
-0.017300
|
7.29e-01
|
8.65e-01
|
|
REACTOME RNA POL II TRANSCRIPTION
|
85
|
8.20e-01
|
9.44e-01
|
0.03920
|
1.47e-02
|
-0.036300
|
8.15e-01
|
5.64e-01
|
|
REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS
|
10
|
9.79e-01
|
9.92e-01
|
0.03780
|
-3.75e-02
|
0.004150
|
8.37e-01
|
9.82e-01
|
|
REACTOME PHOSPHOLIPID METABOLISM
|
113
|
7.83e-01
|
9.44e-01
|
0.03770
|
3.44e-02
|
-0.015600
|
5.30e-01
|
7.76e-01
|
|
REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES
|
167
|
7.03e-01
|
9.22e-01
|
0.03750
|
1.05e-02
|
-0.036000
|
8.15e-01
|
4.25e-01
|
|
REACTOME MEMBRANE TRAFFICKING
|
94
|
8.61e-01
|
9.65e-01
|
0.03330
|
2.68e-02
|
0.019700
|
6.54e-01
|
7.42e-01
|
|
REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX
|
44
|
9.28e-01
|
9.69e-01
|
0.03300
|
2.50e-02
|
-0.021600
|
7.74e-01
|
8.05e-01
|
|
REACTOME SIGNALING BY WNT
|
56
|
9.17e-01
|
9.69e-01
|
0.03280
|
-2.47e-02
|
-0.021700
|
7.50e-01
|
7.79e-01
|
|
REACTOME GAB1 SIGNALOSOME
|
32
|
9.54e-01
|
9.85e-01
|
0.03160
|
-1.19e-02
|
-0.029300
|
9.08e-01
|
7.75e-01
|
|
REACTOME ORC1 REMOVAL FROM CHROMATIN
|
49
|
9.38e-01
|
9.72e-01
|
0.02930
|
7.67e-03
|
-0.028200
|
9.26e-01
|
7.33e-01
|
|
REACTOME SIGNALING BY ILS
|
62
|
9.27e-01
|
9.69e-01
|
0.02910
|
-2.58e-02
|
-0.013400
|
7.26e-01
|
8.55e-01
|
|
REACTOME SIGNALING BY FGFR IN DISEASE
|
79
|
9.06e-01
|
9.69e-01
|
0.02870
|
-7.19e-03
|
0.027800
|
9.12e-01
|
6.70e-01
|
|
REACTOME SYNTHESIS OF DNA
|
59
|
9.28e-01
|
9.69e-01
|
0.02870
|
2.15e-02
|
-0.019000
|
7.76e-01
|
8.01e-01
|
|
REACTOME HOST INTERACTIONS OF HIV FACTORS
|
96
|
8.96e-01
|
9.69e-01
|
0.02810
|
1.59e-02
|
0.023200
|
7.88e-01
|
6.95e-01
|
|
REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
|
40
|
9.64e-01
|
9.86e-01
|
0.02430
|
1.05e-02
|
-0.022000
|
9.09e-01
|
8.10e-01
|
|
REACTOME MITOTIC M M G1 PHASES
|
92
|
9.28e-01
|
9.69e-01
|
0.02330
|
2.57e-03
|
-0.023200
|
9.66e-01
|
7.02e-01
|
|
REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA
|
123
|
9.28e-01
|
9.69e-01
|
0.02040
|
1.94e-02
|
0.006340
|
7.11e-01
|
9.04e-01
|
|
REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION
|
37
|
9.78e-01
|
9.92e-01
|
0.02010
|
2.00e-02
|
-0.002490
|
8.34e-01
|
9.79e-01
|
|
REACTOME SIGNALING BY FGFR
|
67
|
9.63e-01
|
9.86e-01
|
0.01930
|
-5.47e-03
|
0.018500
|
9.38e-01
|
7.94e-01
|
|
REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS
|
274
|
9.00e-01
|
9.69e-01
|
0.01650
|
-8.21e-03
|
-0.014300
|
8.17e-01
|
6.87e-01
|
|
REACTOME ADAPTIVE IMMUNE SYSTEM
|
333
|
8.81e-01
|
9.69e-01
|
0.01630
|
3.51e-03
|
0.015900
|
9.13e-01
|
6.21e-01
|
|
REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21
|
43
|
9.83e-01
|
9.92e-01
|
0.01600
|
1.13e-02
|
-0.011300
|
8.98e-01
|
8.98e-01
|
|
REACTOME APOPTOSIS
|
94
|
9.67e-01
|
9.87e-01
|
0.01570
|
1.42e-02
|
0.006750
|
8.13e-01
|
9.10e-01
|
|
REACTOME DNA REPLICATION
|
102
|
9.64e-01
|
9.86e-01
|
0.01520
|
9.48e-03
|
-0.011900
|
8.69e-01
|
8.36e-01
|
|
REACTOME MRNA PROCESSING
|
137
|
9.55e-01
|
9.85e-01
|
0.01520
|
1.51e-02
|
0.000991
|
7.61e-01
|
9.84e-01
|
|
REACTOME DOWNSTREAM SIGNAL TRANSDUCTION
|
70
|
9.82e-01
|
9.92e-01
|
0.01280
|
6.70e-03
|
-0.011000
|
9.23e-01
|
8.74e-01
|
|
REACTOME TRANSCRIPTION
|
125
|
9.79e-01
|
9.92e-01
|
0.01080
|
-9.81e-03
|
-0.004600
|
8.50e-01
|
9.30e-01
|
|
REACTOME S PHASE
|
69
|
9.90e-01
|
9.96e-01
|
0.01010
|
9.18e-03
|
0.004270
|
8.95e-01
|
9.51e-01
|
|
REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION
|
50
|
9.96e-01
|
9.98e-01
|
0.00730
|
6.39e-03
|
-0.003530
|
9.38e-01
|
9.66e-01
|
|
REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION
|
55
|
9.97e-01
|
9.98e-01
|
0.00585
|
5.55e-03
|
0.001860
|
9.43e-01
|
9.81e-01
|
|
REACTOME MITOTIC PROMETAPHASE
|
41
|
9.98e-01
|
9.98e-01
|
0.00567
|
-2.78e-03
|
-0.004940
|
9.75e-01
|
9.56e-01
|